Mr Marc Laniado: Urology
Search

Mr Marc Laniado

Urology

  • Fee assured
Overview

Specialises in

  • General
  • Urological malignancy

About me

Mr Marc Laniado is a consultant urologist specialising in the diagnosis and treatment of men with prostate enlargement (BPH) and cancer. His aim is to return men to a normal life quickly with the least side effects. Being a consultant since 2002 in the full-time direct clinical care of patients, without other distractions, he has great experience and expertise in the treatment for urinary symptoms due to the prostate (BPH) and the problems associated with prostate cancer. Marc Laniado offers an individualised approach for each man with either prostate enlargement or prostate cancer, tailoring the tests or treatments to the specific values of the man he sees.

For men with urinary symptoms due to BPH, Marc Laniado advises men on lifestyle changes and medications. Where these are unsuccessful, he performs day-case procedures that alleviate urinary symptoms without affecting ejaculation (UroLift). Some men have unsuitable prostates and need either a HoLEP (Holmium Laser Enucleation of the Prostate) or a GLLP (GreenLight Laser Prostatectomy). These are performed as day-case sometimes or overnight stay (> 50 cases a year). To preserve normal ejaculation in selected men, Marc Laniado has modified the procedure successfully.

For men who need therapy for prostate cancer, Marc Laniado offers:



Prolaris: a special way of analysing prostate biopsies that better determines if cancer is very low-risk
Focal therapy with HIFU when appropriate, as it preserves bladder control and erections. If the cancer is unsuitable, he offers either brachytherapy in conjunction with Dr Paul Rogers at the Royal Berkshire Hospital.
Retzius-sparing prostatectomy is the best surgical technique for the preservation of urinary continence and cancer control. He trained in open prostatectomy, started laparoscopic prostatectomies in 2006 and moved onto robotic prostatectomies in 2008/9 with a volume of more than 70 cases per year. He operates regularly at the Royal Berkshire Hospital for NHS patients, where he represents the East Berkshire part of the robotic prostatectomy team.


Marc Laniado is the prostate cancer lead at Wexham Park Hospital (Frimley Health), where he has driven the development of multiparametric MRI and MRI-targeted fusion biopsies of the prostate to diagnose men accurately. He started MRI-targeted biopsies in 2012 and does over two hundred MRI-targeted fusion biopsies a year. He introduced Retzius sparing prostatectomy at the end of 2016 as his preserved surgical technique. He is the primary investigator at Wexham Park for several prostate cancer clinical trials.

By continually increasing his knowledge and awareness of developments in surgical treatments for urological conditions, he brings his expertise and experience to the patient by introducing them into his regular practice, ensuring that patients receive the very best care.

After having graduated from Guy's and St Thomas' medical school, Mr Laniado studied on urological training schemes in London and spent a period at the Cleveland Clinic. He has since gained further recognition and awarded further qualifications and an award from The British Urological Foundation Fellowship, Gilbert Bursary and other awards

Areas of interest

Prostate enlargement using techniques for normal sexual function (UroLift) or shorter hospital stay, less bleeding & catheter time (laser prostatectomy)
Prostate cancer: high PSA, MRI, MRI-targeted transperineal prostate biopsies, SelectMDx, Prolaris) & HIFU, Retzius-sparing prostatectomy

Medical secretaries

Anaesthetists worked with

About me
About my work
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • M4510

    Diagnostic endoscopic examination of bladder (flexible cystoscopy) including any biopsy - (5-50)

    (5-50)

  • M6583

    Transperineal MRI - US fusion targeted prostate biopsy - (5-50)

    (5-50) (1-5)

  • M4514

    Endoscopic examination of bladder (rigid cystoscopy) including any biopsy - (5-50)

    (1-5)

  • M4712

    Bladder instillation of pharmacologic agent (including cystoscopy) - (5-50)

    (1-5)

  • M6533

    Holmium Laser Enucleation of Prostatic Adenoma (HoLEP) - (5-50)

    (5-50)

  • M6192

    Robotic assisted laparoscopic radical prostatectomy, reconstruction of bladder neck including bilateral pelvic lymphadenectomy (including cystoscopy) - (1-5)

    (1-5)

  • M1000

    Therapeutic endoscopic operations on kidney (include cystoscopy and retrograde catheterisation) - (1-5)

    (1-5)

  • M6880

    Insertion of prostatic urethral lift implants (including cystoscopy) - (1-5)

    (1-5)

  • M7940

    Internal urethrotomy (including cystoscopy +/- dilation) - (1-5)

    (1-5)

  • M4410

    Litholapaxy (including cystoscopy) - (1-5)

    (1-5)

  • N1101

    Correction of hydrocele(s) - bilateral - (1-5)

  • M2680

    Endoscopic removal and insertion of prosthesis into ureter (including cystoscopy) - (1-5)

  • N3030

    Circumcision - (1-5)

    (1-5)

  • N0680

    Orchidectomy and excision of spermatic cord (+/- insertion of prosthesis) - (1-5)

    (1-5)

  • M2930

    Removal of prosthesis from ureter (including cystoscopy) - (1-5)

  • M4714

    Therapeutic injection into bladder wall (including cystoscopy) - (1-5)

  • Show All (28)...
Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.